The Multifaceted Challenges of Treating GIST in Pediatric Patients
There are a few major hurdles physicians have to navigate when treating pediatric patients with gastrointestinal stromal tumors.
GIST Insights
Can Artificial Intelligence Be Used to Predict Malignant Potential in GIST?
Artificial intelligence has been shown to have good predictive value for the malignant potential of gastrointestinal stromal tumors.
Beyond Imatinib: Next-Generation TKIs for the Treatment of GIST
Recently developed TKIs such as ripretinib and avapritinib have the potential to change the treatment landscape of GIST.
Diagnosing GIST Preoperatively: Challenges and Advantages
Various studies have analyzed how to better diagnose gastrointestinal stromal tumors at the preoperative stage.
Should Imatinib Be Discontinued in Patients With Advanced GIST?
We explore how imatinib became the first-line therapy for metastatic GIST, and whether it should be discontinued in some circumstances.
Targeting the PDGF/PDGFR Pathway in Cancer Research
We discuss current therapeutic strategies in targeting the PDGF/PDGFR signaling pathway in cancer research.
The Benefits of Laparoscopic Surgery vs Open Surgery for GIST
We describe the numerous benefits that laparoscopic surgery confers to patients with GIST, compared to open surgery.
How Patient Education Impacts Adherence to Imatinib Among Patients With GIST
We explore a Chinese study on adherence to imatinib among GIST patients and how patient adherence can be improved in general.
A Rare Case Report of Ovarian Metastasis in GIST
Yamagachi and colleagues described a rare case report of a female patient with a gastrointestinal stromal tumor with ovarian metastasis.
Comparing Patient Outcomes Before and After the Introduction of Imatinib
We explore the impact of imatinib on outcomes of patients with gastrointestinal stromal tumors, as well as ways to prevent resistance to it.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in GIST Insights
Loading... 
Loading...